PMMI ProSource – Start Your Search
Check out our packaging and processing solutions finder, PMMI ProSource.

FDA Approves World’s First RSV Vaccine

RSV cases have increased dramatically in recent years, with outbreaks occurring across the U.S. and in other parts of the world.

Screen Shot 2022 04 18 At 2 43 12 Pm
Getty Images

According to a recent Vox article, the FDA  has granted approval for the first-ever vaccine to prevent respiratory syncytial virus (RSV) in adults. The vaccine, called Arexvy, was developed by AstraZeneca and is designed to protect against the virus, which can cause serious respiratory illness, particularly in older adults and those with weakened immune systems. The approval of Arexvy represents a significant step forward in the fight against RSV, which has long been a major cause of illness and death worldwide.